Cite
Kazory A, Racusen LC, Berliner AR, et al. Mycophenolate mofetil as a possible therapeutic option for idiopathic membranoproliferative glomerulonephritis. NDT Plus. 2008;1(6):466-468doi: 10.1093/ndtplus/sfn102.
Kazory, A., Racusen, L. C., Berliner, A. R., Gimenez, L. F., & Jaar, B. G. (2008). Mycophenolate mofetil as a possible therapeutic option for idiopathic membranoproliferative glomerulonephritis. NDT plus, 1(6), 466-468. https://doi.org/10.1093/ndtplus/sfn102
Kazory, Amir, et al. "Mycophenolate mofetil as a possible therapeutic option for idiopathic membranoproliferative glomerulonephritis." NDT plus vol. 1,6 (2008): 466-468. doi: https://doi.org/10.1093/ndtplus/sfn102
Kazory A, Racusen LC, Berliner AR, Gimenez LF, Jaar BG. Mycophenolate mofetil as a possible therapeutic option for idiopathic membranoproliferative glomerulonephritis. NDT Plus. 2008 Dec;1(6):466-468. doi: 10.1093/ndtplus/sfn102. Epub 2008 Aug 21. PMID: 28656986; PMCID: PMC5477861.
Copy
Download .nbib